Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zongqi,Shi

第一单位： Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.

作者： Zongqi,Shi ^[1] ; Huizhi,Zheng ^[2] ; Miaomiao,Han ^[1] ; Jieli,Hu ^[1] ; Yuan,Hu ^[1] ; Xiaosong,Li ^[1] ; Wenyan,Zhu ^[1] ; Xinjun,He ^[3] ; Haijun,Deng ^[3] ; Quanxin,Long ^[1] ; Ailong,Huang ^[1]

作者单位： Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China. ^[1] Medical Data Research Institute of Chongqing Medical University, Chongqing 400010, China. ^[2] YiduCloud (Beijing) Technology Co.,Ltd, Beijing 100089, China. ^[3]

关键词 Chronic hepatitis B Infection Clinical outcomes after HBsAg seroclearance Durability of HBsAg seroclearance Interferon monotherapy Nucleoside analogs monotherapy anti-HBs

DOI 10.1016/j.gendis.2022.03.003

PMID 37396526

发布时间 2023-07-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Genes & diseases

2023年10卷3期

1019-1028页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record.

Genes & diseases

相似文献

Genes & diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record.

Genes & diseases

相似文献

Genes & diseases

相关期刊

检索历史清除